Work Expert (WE) is an independent publishing and referral website. We are not a recruiter, hiring manager, agent or employer, and we are not affiliated with or endorsed by Mercor. Applying takes you to the platform's own website, where we may be recorded as the referring source. We may receive a referral fee at no additional cost to you. Read our full affiliate disclosure →
About the Role
Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a payer / market access expert for a paid pilot, with the potential to continue as the work scales.
What You'll Do
Create and critique rubrics that analyze commercial drugs and drug-development programs
Set and pressure-test gross-to-net and formulary-tier assumptions by drug class
Judge whether coverage, rebating, and tiering assumptions reflect how payers actually behave
Apply this across the pilot's set of drugs and drug classes
You're a Good Fit If You
US-based payer / market access professional
Familiarity with biotech/pharma development programs
Hands-on with gross-to-net, rebates, and formulary tiering by drug class
5+ years in market access, pricing & reimbursement, or managed markets
Independent contractor engagement. Apply via the link below - Mercor handles onboarding and pays weekly via Stripe or Wise.
Common Questions
Mercor has a reliability rating of very reliable based on the listings we track, with an onboarding time of 1-3 weeks (interview + assessment + trial). See our full Mercor review for the details behind that rating.
Applying takes you to Mercor's own website, where the application is completed. We are not a recruiter or employer and do not process applications directly - we may be recorded as the referring source.
$175-$200/h - Independent contractor engagement. Apply via the link below - Mercor handles onboarding and pays weekly via Stripe or Wise.
Create and critique rubrics that analyze commercial drugs and drug-development programs Set and pressure-test gross-to-net and formulary-tier assumptions by drug class Judge whether coverage, rebating, and tiering assumptions reflect how payers actually behave
